We are testing a combination of two immunotherapy drugs for patients with metastatic colorectal cancer that is resistant to previous treatments. This study aims to find out if this combination can improve outcomes for these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic colorectal cancer is a stage of cancer where the disease has spread from the colon or rectum to other organs, such as the liver or lungs, often leading to symptoms like abdominal pain, weight loss, and changes in bowel habits.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.